Journal of Hepatology
Volume 51, Issue 1 , Pages 156-160 , July 2009

Mycophenolate mofetil as rescue treatment for autoimmune liver disease in children: A 5-year follow-up

  • Marion M. Aw

      Affiliations

    • Department of Paediatrics, National University of Singapore, Singapore
    • ,
  • Anil Dhawan

      Affiliations

    • Paediatric Liver Centre, King’s College London School of Medicine, King’s College Hospital, Denmark Hill, London SE5 9RX, United Kingdom
    • Corresponding Author InformationCorresponding author. Tel.: +44 020 3299 4408; fax: +44 020 3299 4228.
    • ,
  • Marianne Samyn

      Affiliations

    • Paediatric Liver Centre, King’s College London School of Medicine, King’s College Hospital, Denmark Hill, London SE5 9RX, United Kingdom
    • ,
  • Aikaterini Bargiota

      Affiliations

    • Paediatric Liver Centre, King’s College London School of Medicine, King’s College Hospital, Denmark Hill, London SE5 9RX, United Kingdom
    • ,
  • Giorgina Mieli-Vergani

      Affiliations

    • Paediatric Liver Centre, King’s College London School of Medicine, King’s College Hospital, Denmark Hill, London SE5 9RX, United Kingdom

Received 3 October 2008 ,Revised 5 February 2009 ,Accepted 12 February 2009.

References 

  1. Johnson PJ, McFarlane IG. Meeting report: International Autoimmune Hepatitis Group. Hepatology. 1993;18:998–1005
  2. Gregorio GV, Portmann B, Reid F, Donaldson PT, Doherty DG, McCartney M, et al. Autoimmune hepatitis in childhood: A 20-year experience. Hepatology. 1997;25:541–547
  3. Gregorio GV, Portmann B, Reid F, Harrison P, Donaldson PT, Vergani D, et al. Autoimmune hepatitis/sclerosing cholangitis overlap syndrome in childhood: a 16-year prospective study. Hepatology. 2001;33:544–553
  4. Saadah OI, Smith AL, Hardikar W. Long-term outcome of autoimmune hepatitis in children. J Gastroenterol Hepatol. 2001;16:1297–1302
  5. Richardson PD, James PD, Ryder SD. Mycophenolate mofetil for maintenance of remission in autoimmune hepatitis in patients resistant to or intolerant of azathioprine. J Hepatol. 2000;33:371–375
  6. Devlin SM, Swain MG, Urbanski SJ, Burak KW. Mycophenolate mofetil for the treatment of autoimmune hepatitis in patients refractory to standard therapy. Can J Gastroenterol. 2004;18:321–326
  7. Chatru N, Ramji A, Bain VG, Ma MM, Marotta PJ, Ghent CN, et al. Transplant immunosuppressive agents in non-transplant chronic autoimmune hepatitis: the Canadian association for the study of liver experience with mycophenolate mofetil. Liver Int. 2005;25:723–777
  8. Inductivo-Yu I, Adams A, Gish RG, Wakil A, Bzowej NH, Frederick RT, et al. Mycophenolate mofetil in autoimmune hepatitis patients not responsive or intolerant to standard immunosuppressive therapy. Clin Gastroenterol Hepatol. 2007;5:799–802
  9. Czaja AJ, Freeze DK. Diagnosis and treatment of autoimmune hepatitis. Hepatology. 2002;36:479–497
  10. Alvarez F, Ciocca M, Canero-Velasco C, Ramonet M, de Davila MT, Cuarterolo M, et al. Short-term cyclosporine induces a remission of autoimmune hepatitis in children. J Hepatol. 1999;30:222–227
  11. Debray D, Maggiore G, Girardet JP, Mallet E, Bernard O. Efficacy of cyclosporin A in children with type 2 autoimmune hepatitis. J Pediatrics. 1999;135:111–114
  12. Malekzadeh R, Nasseri-Moghaddam S, Kaviani MJ, Taheri H, Kamalian N, Sotoudeh M. Cyclosporin A is a promising alternative to corticosteroids in autoimmune hepatitis. Dig Dis Sci. 2001;46:1321–1327
  13. Fernandes NF, Redeker AG, Vierling JM, Villamil FG, Fong TL. Cyclosporine therapy in patients with steroid resistant autoimmune hepatitis. Am J Gastroenterol. 1999;94:241–248
  14. Sherman KE, Narkewicz M, Pinto PC. Cyclosporine in the management of corticosteroid-resistant type I autoimmune chronic active hepatitis. J Hepatol. 1994;21:1040–1047
  15. Allison AC, Eugui EM. Preferential suppression of lymphocyte proliferation by mycophenolic acid and predicted long-term effects of mycophenolate mofetil in transplantation. Transplant Proc. 1994;26:3205
  16. Woodroffe R, Yao G, Meads C, Bayliss S, Ready A, Raftery J, et al. Clinical and cost-effectiveness of newer immunosuppressive regimens in renal transplantation: a systematic review and modeling study. Health Technol Assess. 2005;9:1–179
  17. Czaja AJ, Bianchi FB, Carpenter HA, Krawitt EL, Lohse AW, Manns MP, et al. Treatment challenges and investigational opportunities in autoimmune hepatitis. Hepatology. 2005;41:207–215

☆ The authors who have taken part in this study do not have a relationship with the manufacturers of the drug involved either in the past or present and did not receive funding from the manufacturers to carry out their research.

PII: S0168-8278(09)00177-9

doi: 10.1016/j.jhep.2009.02.024

Journal of Hepatology
Volume 51, Issue 1 , Pages 156-160 , July 2009

Article Tools

* Image Usage & Resolution